Aggressive posterior retinopathy of prematurity: a pilot study of quantitative analysis of vascular features
- PMID: 25413261
- PMCID: PMC12329759
- DOI: 10.1007/s00417-014-2857-2
Aggressive posterior retinopathy of prematurity: a pilot study of quantitative analysis of vascular features
Abstract
Purpose: To evaluate aggressive posterior retinopathy of prematurity (AP-ROP) with regard to inter-expert diagnostic agreement and quantitative vascular features.
Methods: Eight ROP experts interpreted 15 retinal images for AP-ROP and plus disease. Inter-expert agreement was calculated by absolute agreement for AP-ROP and plus, and kappa statistic for each expert was compared with others. Retinal vessels were analyzed by a computer-based system to calculate diameter and integrated curvature (IC). Consensus reference standards for images were developed, and quantitative parameters for arterioles and venules were compared among images with AP-ROP vs. not AP-ROP, plus vs. not plus, and AP-ROP vs. plus.
Results: Mean kappa for each expert in AP-ROP diagnosis ranged from -0.15 (no agreement) to 0.42 (moderate agreement). Nine (30 %) of 30 total AP-ROP diagnoses were also classified as not plus disease. Analysis of images with AP-ROP vs. plus showed that images with AP-ROP had higher venular IC (p = 0.04). Arteriolar IC was statistically significant between images with AP-ROP vs. not AP-ROP (p = 0.01) and plus vs. not plus (p = 0.00003). There were no statistically significant differences in diameter between image groups.
Conclusions: Inter-expert agreement with regard to AP-ROP diagnosis is imperfect. Venular curvature may be a distinguishing characteristic between AP-ROP and plus. Future studies involving quantitative features of AP-ROP will have benefits for clinical diagnosis and management.
Conflict of interest statement
MFC is an unpaid member of the Scientific Advisory Board for Clarity Medical Systems (Pleasanton, CA, USA).
Figures



Comment in
-
Experts contradict established classification.Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):199. doi: 10.1007/s00417-015-3106-z. Epub 2015 Jul 21. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26194405 No abstract available.
-
Science and art in retinopathy of prematurity diagnosis.Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):201-2. doi: 10.1007/s00417-015-3107-y. Epub 2015 Jul 22. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26198712 Free PMC article. No abstract available.
References
-
- Early Treatment For Retinopathy Of Prematurity Cooperative Group (2005) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121:1684–1694 - PubMed
-
- Palmer EA, Hardy RJ, Dobson V et al. (2005) 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 123:311–318 - PubMed
-
- Silverman WA (1980) Retrolental Fibroplasia: A Modern Parable. Grune and Stratton, Inc., New York, NY
-
- Vinekar A, Avadhani K, Braganza S et al. (2011) Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2. Am J Ophthalmol 152:712. - PubMed
-
- International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123:991–999 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources